Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-04 Lamond David Director Purchase +15,969 $36.34 $580K 1,793,009
2021-03-04 Lamond David Director Purchase +4,100 $36.86 $151K 1,797,109
2021-02-09 Monohon Ted Chief Accounting Officer Grant or award · Employee Stock Option (right to buy) +20,000 20,000
2021-02-09 LOWE CHRISTOPHER P. COO & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2021-02-03 Lynch Casey Chief Executive Officer Sale −400 $37.39 $15K 1,058,374
2021-02-03 Lynch Casey Chief Executive Officer Sale −1,600 $38.64 $62K 1,056,774
2021-02-03 Lynch Casey Chief Executive Officer Sale −856 $39.82 $34K 1,055,918
2021-02-03 Lynch Casey Chief Executive Officer Sale −2,000 $40.84 $82K 1,053,918
2021-02-03 Lynch Casey Chief Executive Officer Sale −3,100 $41.91 $130K 1,050,818
2021-02-03 Lynch Casey Chief Executive Officer Sale −1,512 $43.10 $65K 1,049,306
2021-02-03 Lynch Casey Chief Executive Officer Sale −1,900 $44.22 $84K 1,047,406
2021-02-03 Lynch Casey Chief Executive Officer Sale −8,032 $45.00 $361K 1,039,374
2021-02-03 Lynch Casey Chief Executive Officer Sale −600 $45.73 $27K 1,038,774
2021-02-02 Lynch Casey Chief Executive Officer Sale −14,929 $36.02 $538K 1,063,845
2021-02-02 Lynch Casey Chief Executive Officer Sale −5,071 $36.75 $186K 1,058,774
2021-02-01 Lynch Casey Chief Executive Officer Sale −4,686 $34.60 $162K 1,094,088
2021-02-01 Lynch Casey Chief Executive Officer Sale −3,100 $35.59 $110K 1,090,988
2021-02-01 Lynch Casey Chief Executive Officer Sale −7,460 $36.56 $273K 1,083,528
2021-02-01 Lynch Casey Chief Executive Officer Sale −4,283 $37.68 $161K 1,079,245
2021-02-01 Lynch Casey Chief Executive Officer Sale −100 $38.28 $4K 1,079,145

Page 12 of 18 · 350 trades